gip/glp-1 agonists The Sustained Effects of a Dual Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes Potential Use of GLP-1 and

Dysregulation of carnitine metabolism in DKD In contrast to the tightly regulated carnitine homeostasis under physiological conditions, the progression of DKD disrupts the renal homeostasis of carnitine metabolismgoverned by synthesis, absorption, and excretionleading to significant regional heterogeneity and systemic metabolic dysfunction

10.1136/bmj.1.6010.626-a 318 TeoY

Erastin triggers autophagic death of breast cancer cells by increasing intracellular iron levels

Founded by Jarred Mait, MD, Pulse & Remedy is committed to delivering premium concierge medical care in South Florida

FDA to Review 7 Peptides for 503A Bulks List Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List: BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon